Dell Faulkingham, SVP, CCO at Akebia Therapeutics, Inc. (AKBA), sold 952 shares at $3.40 ($3K) on 2021-04-01, disclosed to the SEC on 2021-04-01.
Open-market sale of $3k AKBA by SVP, CCO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AKBA | SELL | 2020-06-02 | $149K | — | Filing → |